Figure 5. The survival curves of the FRlncRNAs signature stratified by age, grade, stage, gender, etiology, radiotherapy, and family history.

(A) ≥ 65 years, (B) <65 years, (C) grade 1–2, (D) grade 3–4, (E) stage 1–2, (F) stage 3–4, (G) Alcoholic liver disease, (H) NAFLD, (I) no family history, (J) male, (K) HBV positive, (L) HBV and HCV negative, (M) no radiotherapy patients.